Patent holdings for IPC class A61K 9/20

Total number of patents in this class: 14243

10-year publication summary

1062
1156
1082
1176
1162
1136
1003
962
927
925
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Novartis AG
10626
143
Sanovel Ilac Sanayi ve Ticaret A.S.
287
137
Fertin Pharma A/S
260
107
Antecip Bioventures II LLC
346
105
Boehringer Ingelheim International GmbH
4637
96
Axsome Therapeutics, Inc.
280
93
Takeda Pharmaceutical Company Limited
2716
88
ratiopharm GmbH
300
83
Synthon BV
309
77
Daiichi Sankyo Company, Limited
1880
76
Merck Patent GmbH
5755
71
Purdue Pharma L.P.
495
71
Hanmi Pharm. Co., Ltd.
576
68
Vertex Pharmaceuticals Incorporated
1621
65
Gilead Sciences, Inc.
2085
65
AstraZeneca AB
2851
61
Novo Nordisk A/S
2281
60
Hoffmann-La Roche Inc.
3534
57
Astellas Pharma Inc.
1053
53
Lupin Limited
432
53
Other owners 12614